Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT06238115

Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair (TEAR)

Prophylactic Administration of Tirofiban for Preventing Thromboembolic Events in Stent-assisted Coiling and Flow Diversion Treatments of Unruptured Intracranial Aneurysms

Sponsor: Beijing Tiantan Hospital

Conditions Flow Diverter Stent-assisted Coiling Thromboembolic Events Unruptured Intracranial Aneurysm

Interventions Tirofiban aspirin, clopidogrel

Updated 5 times since 2024 Last updated: Dec 4, 2025 Started: Mar 4, 2024 Primary completion: Oct 9, 2025 Completion: Nov 9, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06238115, this PHASE2/PHASE3 trial focuses on Flow Diverter and Stent-assisted Coiling and remains completed. Sponsored by Beijing Tiantan Hospital, it has been updated 5 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE2/PHASE3

Status: Recruiting → Completed
Sep 2024 — Jan 2026 [monthly]

Recruiting PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Apr 2024 — Jul 2024 [monthly]

Recruiting PHASE2_PHASE3
Mar 2024 — Apr 2024 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Tiantan Hospital

Data source: Beijing Tiantan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China